Trial
NCT01229202
Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Nova Scotia Health Authority
Collaborators
—
Condition
Glaucoma
Intervention
Bevacizumab
Why stopped
No REB file
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-21